Progres en Urologie

Papers
(The H4-Index of Progres en Urologie is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : cancer de la prostate65
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : tumeurs de la vessie25
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease25
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein20
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer20
Positive environmental impact of remote teleconsultation in urology during the COVID-19 pandemic in a highly populated area19
Pulsed lasers and endocorporeal laser lithotripsy18
When residents work less, they feel better: Lessons learned from an unprecedent context of lockdown16
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)12
Semen parameters and sex hormones as affected by SARS-CoV-2 infection: A systematic review11
Sperm DNA status in infertile patients with clinical varicocele11
TFPI-2 inhibits the invasion and metastasis of bladder cancer cells11
0.050064086914062